Overshadowed by the Pill – Die Entwicklung männlicher Langzeitverhütungsmittel
DOI: 10.61387/S.2017.12.3
Autoren
Miriam Klemm
Abstract
The 20th C. witnessed the development of numerous contra- ceptive technologies directed at the female reproductive body, but none directed at the sperm-producing body. Efforts to develop a long-acting, reversible contraceptive for men” have been intensified since the 1970s, for example by the WHO, which established its Task Force on the Regulation in the Male of the Fertilizing Ability of Sperm (Male Task Force) in 1972. Since the pharmaceutical industry has not been involved in the development of male contraceptives, actors from the public sector, such as the WHO, have created niches in which knowledge about the male reproductive body can be pro- duced, concepts tested, and networks between experts and activists established. In an historical overview, I will sketch out the economic, cultural and scientific barriers facing these actors while innovating male contraception. Presently, the National Institute of Health and the Parsemus Foundation in the USA as well as the Indian Council of Medical Research in India and the International Consortium for Male Contraception are shaping the field of male contraceptive development. I will analyze their various innovation strategies. While Western actors frame their work in terms of gender equality, Indian actors focus on the development and legitimization of an indigenous Indian, non-hormonal product.
Keywords
Male Contraception, Contraception development, Gender, Innovation strategies
Metadaten
Veröffentlicht in: Sexuologie. Zeitschrift für Sexualmedizin, Sexualtherapie und Sexualwissenschaft. Band 24 • Jahr 2017 • Heft 1-2, Seiten 11-18